Colchicine Tablet
NDC Package 72189-331-03

The code 72189-331-03 identifies a specific commercial package of 3 tablet in 1 bottle of Colchicine, a human prescription drug labeled by Direct Rx. This product is billed for "EA" each discreet unit and contains an estimated amount of 3 billable units per package. This tablet is formulated for oral use and contains colchicine as the active substance.

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Direct Rx on March 01, 2022. The current certification is valid through December 31, 2026.

This medication is used to prevent or treat gout attacks (flares). Usually gout symptoms develop suddenly and involve only one or a few joints. The big toe, knee, or ankle joints are most often affected. Gout is caused by too much uric acid in the blood. When uric acid levels in the blood are too high, the uric acid may form hard crystals in your joints. Colchicine works by decreasing swelling and lessening the build up of uric acid crystals that cause pain in the affected joint(s). This medication is also used to prevent attacks of pain in the abdomen, chest, or joints caused by a certain inherited disease (familial Mediterranean fever). It is thought to work by decreasing your body's production of a certain protein (amyloid A) that builds up in people with familial Mediterranean fever. Colchicine is not a pain medication and should not be used to relieve other causes of pain.

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72189033103. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 3 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.